Gulf Lab & Radiology’s molecular diagnostics section uses real-time PCR and nucleic acid amplification technology (NAAT) to provide rapid, highly sensitive detection of viral, bacterial, and genetic targets from a variety of specimen types.
Molecular Diagnostics (PCR) Overview
Our PCR platform supports respiratory, STI, hepatitis viral load, HIV monitoring, and antimicrobial resistance panels, with same-day results for priority targets.
- Respiratory multiplex PCR: COVID-19, Influenza A/B, RSV
- STI panel: Chlamydia, Gonorrhoea, Trichomonas, Mycoplasma
- Hepatitis B & C viral load quantification
- HIV-1/2 viral load (ART monitoring & diagnosis)
- HPV genotyping, TB (Xpert MTB/RIF) & C. difficile
- Turnaround: 4u20136 hours (COVID-19: same day)
Frequently Asked Questions
PCR detects the DNA/RNA of the pathogen directly, making it highly sensitive even when bacterial load is low. Culture-based methods depend on the organism surviving specimen transport and growing under laboratory conditions u2014 factors that can lead to false-negative results.
Depending on the test, specimens may include urogenital swabs (cervical, urethral, vaginal), urine (first-void), or throat/rectal swabs. Our team will advise on the appropriate specimen type for your specific test at the time of booking.
No. A positive HPV test means you have been infected with one or more strains of HPV. Most HPV infections resolve spontaneously. High-risk strains (16 and 18) are associated with an increased risk of cervical and other cancers over time. Regular cervical screening (Pap smear/colposcopy) alongside HPV testing allows early detection of pre-cancerous changes.
PCR results are typically available within 24 hours of specimen receipt. GeneXpert assays can produce preliminary results in as little as 90 minutes in urgent situations.
Yes. All laboratory results, particularly those relating to STIs, are strictly confidential and are released only to the patient and their nominated physician in accordance with our privacy policy.